Aromatic L-amino acid decarboxylase inhibitor

This page covers all Aromatic L-amino acid decarboxylase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Aromatic L-amino acid decarboxylase.

Targets

Aromatic L-amino acid decarboxylase

Phase 2 pipeline (2)

• Carbidopa Low-Dose · NYU Langone Health · Neurology
  Carbidopa is a decarboxylase inhibitor that prevents the conversion of levodopa to dopamine, thereby increasing the availability of levodopa in the brain.
• Carbidopa High-Dose · NYU Langone Health · Movement Disorders
  Carbidopa is a decarboxylase inhibitor that prevents the conversion of levodopa to dopamine, thereby increasing the availability of levodopa in the brain.